Immune Responses against Disseminated Tumor Cells

por Peng, Ling, Zhang, Yongchang, Wang, Zibing
Publicado 2021

Case Report: PD-1 Inhibitor Is Active in Lung Adenocarcinoma With B Cell Deficiency

por Yuan, Shumin, Hu, Xiufeng, Zhao, Yanqiu, Wang, Zibing
Publicado 2020

Adjusting the dose of traditional drugs combined with immunotherapy: reshaping the immune microenvironment in lung cancer

por Wang, Linlin, Du, Changqi, Jiang, Bing, Chen, Lin, Wang, Zibing
Publicado 2023

MDSC-decreasing chemotherapy increases the efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma and pancreatic cancer

por Wang, Zibing, Liu, Yuqing, Zhang, Yong, Shang, Yiman, Gao, Quanli
Publicado 2015

Pretreatment Peripheral B Cells Are Associated With Tumor Response to Anti-PD-1-Based Immunotherapy

por Yuan, Shumin, Liu, Yuqing, Till, Brian, Song, Yongping, Wang, Zibing
Publicado 2020

Immunotherapy-Related Cystitis: Case Report and Review of the Literature

por Zhu, Liping, Wang, Zhiqiang, Stebbing, Justin, Wang, Zibing, Peng, Ling
Publicado 2021

Combination of Cytokine-Induced Killer Cells and Programmed Cell Death-1 Blockade Works Synergistically to Enhance Therapeutic Efficacy in Metastatic Renal Cell Carcinoma and Non-S...

por Wang, Zibing, Liu, Xiaoli, Till, Brian, Sun, Miaomiao, Li, Xiang, Gao, Quanli
Publicado 2018

Advanced Renal-Cell Carcinoma Pseudoprogression After Combined Immunotherapy: Case Report and Literature Review

por Zhang, Xiaojie, Huang, Hao, Han, Lu, Li, Tiepeng, Wang, Zibing, Gao, Quanli
Publicado 2021

Axitinib Reverses Resistance to Anti-Programmed Cell Death-1 Therapy in a Patient With Renal Cell Carcinoma

por Yang, Yonghao, Huang, Hao, Li, Tiepeng, Gao, Quanli, Song, Yongping, Wang, Zibing
Publicado 2021

Aspirin, a Potential GLUT1 Inhibitor in a Vascular Endothelial Cell Line

por Hu, Yabo, Lou, Xiaohan, Wang, Ruirui, Sun, Chanjun, Liu, Xiaomeng, Liu, Shuochuan, Wang, Zibing, Ni, Chen
Publicado 2019

Tumor-specific activatable biopolymer nanoparticles stabilized by hydroxyethyl starch prodrug for self-amplified cooperative cancer therapy

por Xiong, Yuxuan, Wang, Zibing, Wang, Qiang, Deng, Qingyuan, Chen, Jitang, Wei, Jianshuang, Yang, Xiaoquan, Yang, Xiangliang, Li, Zifu
Publicado 2022

Toxic Epidermal Necrolysis-Like Reaction Following Combination Therapy With Camrelizumab and Apatinib for Advanced Gallbladder Carcinoma

por Yang, Yonghao, Li, Jun, Till, Brian G., Wang, Jun, Zhang, Bicheng, Wang, Hanping, Huang, Hao, Li, Tiepeng, Gao, Quanli, Li, Hongle, Wang, Zibing
Publicado 2021

Identification of novel HLA-A*11:01-restricted HPV16 E6/E7 epitopes and T-cell receptors for HPV-related cancer immunotherapy

por Xiong, Chengjie, Huang, Lihong, Kou, Hedan, Wang, Chenwei, Zeng, Xiaomin, Sun, Hanli, Liu, Shangyuan, Wu, Bin, Li, Jingyao, Wang, Xiaoling, Wang, Zibing, Chen, Lin
Publicado 2022

Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma

por Yuan, Shumin, Fu, Qiang, Zhao, Lingdi, Fu, Xiaomin, Li, Tiepeng, Han, Lu, Qin, Peng, Ren, Yingkun, Huo, Mingke, Li, Zhimeng, Lu, Chaomin, Yuan, Long, Gao, Quanli, Wang, Zibing
Publicado 2022

Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancer

por Ma, Baozhen, Zhou, Yu, Shang, Yiman, Zhang, Yong, Xu, Benling, Fu, Xiaomin, Guo, Jindong, Yang, Yonghao, Zhang, Fang, Zhou, Mengyuan, Huang, Hao, Li, Fanghui, Lin, Hongwei, Zhao, Lingdi, Wang, Zibing, Gao, Quanli
Publicado 2022

Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer

por Wang, Zibing, Liu, Yuqing, Li, Rui’e, Shang, Yiman, Zhang, Yong, Zhao, Lingdi, Li, Wei, Yang, Yonghao, Zhang, Xiaojie, Yang, Tiejun, Nie, Changfu, Han, Feng, Liu, Ying, Luo, Suxia, Gao, Quanli, Song, Yongping
Publicado 2016

High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-...

por Zhao, Lingdi, Li, Tiepeng, Song, Yongping, Yang, Yonghao, Ma, Baozhen, Zhang, Yong, Shang, Yiman, Xu, Benling, Guo, Jindong, Qin, Peng, Han, Lu, Fu, Xiaomin, Lin, Hongwei, Liu, Liang, Ren, Xiubao, Wang, Zibing, Gao, Quanli
Publicado 2022

Combination of Low-Dose Gemcitabine and PD-1 Inhibitors for Treatment in Patients With Advanced Malignancies

por Huang, Hao, Peng, Ling, Zhang, Bicheng, Till, Brian G., Yang, Yonghao, Zhang, Xiaojie, Zhao, Lingdi, Fu, Xiaomin, Li, Tiepeng, Han, Lu, Qin, Peng, Chen, Lin, Yan, Xiang, Liu, Yang, Wang, Wenkang, Ye, Zhenlong, Li, Hongle, Gao, Quanli, Wang, Zibing
Publicado 2022

The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer—A Phase II Study

por Xing, Wenqun, Zhao, Lingdi, Zheng, Yan, Liu, Baoxing, Liu, Xianben, Li, Tiepeng, Zhang, Yong, Ma, Baozhen, Yang, Yonghao, Shang, Yiman, Fu, Xiaomin, Liang, Guanghui, Yuan, Dongfeng, Qu, Jinrong, Chai, Xiaofei, Zhang, He, Wang, Zibing, Lin, Hongwei, Liu, Liang, Ren, Xiubao, Zhang, Jiangong, Gao, Quanli
Publicado 2021